Related Experiment Video
Updated: Dec 23, 2025
Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
Published on: November 20, 2012
Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development
Michael Ruff1,2, Sani Kizilbash2, Jan Buckner2
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Abstract:
Introduction: Recent discoveries in the molecular makeup of gliomas, the relationship of certain molecular drivers, and the patient's response to therapy and overall prognosis have resulted in a paradigm shift and redefined our understanding of glioma and revealed potential vulnerabilities within this recalcitrant and lethal disease.Areas covered: We summarize the current classification of malignant glioma in the context of the historical background, current data-driven treatment strategies, and recent discoveries of the mechanisms of pathogenesis of this disease which recapitulates the developing brain. We describe the relationship to common genetic alterations found in glioma, and possible avenues to exploit these newly revealed mechanisms.Expert opinion: Improved understanding of the molecular underpinnings of this disease has been directly translated into treatment decisions and an improved ability to counsel patients regarding their prognosis. We are beginning to see the first glimmer of a return on the investment in regard to immunotherapy in malignant glioma, with further anticipated successful exploitations of the unique pathophysiology of glioma.
Insights
Recent molecular discoveries have redefined glioma understanding, revealing vulnerabilities and improving patient prognosis. New insights into glioma pathogenesis offer potential therapeutic targets, including immunotherapy.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Malignant gliomas are lethal brain tumors with complex molecular landscapes.
- Previous understanding of glioma pathogenesis has been limited, hindering effective treatment strategies.
Purpose of the Study:
- To summarize the current classification and historical context of malignant glioma.
- To review data-driven treatment strategies and recent discoveries in glioma pathogenesis.
- To explore the relationship between genetic alterations and potential therapeutic vulnerabilities.
Main Methods:
- Literature review of current glioma classification and molecular mechanisms.
- Analysis of genetic alterations and their role in glioma development.
- Synthesis of current and emerging treatment strategies, including immunotherapy.
Main Results:
- Molecular discoveries have shifted the paradigm in understanding glioma.
- Genetic alterations are closely linked to glioma pathogenesis and patient prognosis.
- Immunotherapy shows early promise for treating malignant glioma.
Conclusions:
- Improved molecular understanding of glioma directly impacts treatment decisions and prognostic counseling.
- Exploiting the unique pathophysiology of glioma, particularly through immunotherapy, holds significant therapeutic potential.
